144 studies found for:    Emtricitabina/ Fumarato de disoproxilo de tenofovir OR Truvada[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: raltegravir (Isentress);   Drug: Truvada®
22 Recruiting On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Condition: HIV Infection
Interventions: Drug: Truvada;   Drug: Placebo
23 Unknown  The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
Conditions: Primary HIV (Acute or Early);   Chronic HIV Infection
Intervention: Drug: Tenofovir disoproxil fumarate and emtricitabine (TDF/FTC; Truvada) plus the integrase inhibitor, raltegravir.
24 Not yet recruiting A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
Conditions: Infection;   HIV
Intervention: Drug: Truvada and Isentress
25 Completed
Has Results
Safety and Efficacy Study of Switching From Epzicom to Truvada
Condition: HIV Infection
Interventions: Drug: emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF);   Drug: abacavir (ABC)/lamivudine (3TC)
26 Withdrawn A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Drug: Raltegravir plus Truvada;   Drug: Atripla
27 Unknown  Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
28 Unknown  The First Failure Study
Conditions: HIV;   HIV Infections
Interventions: Drug: Darunavir, Ritonavir, Truvada;   Drug: Darunavir, Ritonavir and Etravirine
29 Recruiting Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: raltegravir plus truvada;   Drug: Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)
30 Recruiting Atripla to Raltegravir Switch Study
Condition: HIV Infection
Intervention: Drug: Truvada/Raltegravir
31 Completed Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM5)(COMPLETED)
Condition: HIV Infections
Interventions: Drug: Vicriviroc;   Drug: emtricitabine and tenofovir disoproxil fumarate
32 Not yet recruiting SCOPE: Strategies to Combine PrEP With Prevention Efforts
Condition: HIV
Intervention: Drug: Once daily Truvada®
33 Recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
34 Not yet recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
35 Active, not recruiting Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Conditions: Stimulant-Related Disorders;   HIV;   HIV Infections
Intervention: Drug: Truvada
36 Completed
Has Results
Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada
Condition: HIV-1
Interventions: Drug: Truvada;   Drug: Zidovudine/lamivudine
37 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
38 Completed SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada
Condition: HIV-1 Infection
Intervention: Drug: Truvada
39 Completed SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: zidovudine and lamivudine (Combivir®);   Drug: emtricitabine and tenofovir DF
40 Recruiting Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years